Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Pavlos Papakostas"'
Autor:
Foteinos-Ioannis Dimitrakopoulos, Kyriaki Papadopoulou, Dimitrios Pectasides, Anna Batistatou, Kitty Pavlakis, George Fountzilas, Helen P. Kourea, Sofia Chrisafi, George Pentheroudakis, Vassiliki Kotoula, Pavlos Papakostas, Eleni Galani, Eleni Res, Dimitrios Bafaloukos, Angelos Koutras, Georgia-Angeliki Koliou, Mattheos Bobos, Kyriakos Chatzopoulos, Anthoula Asimaki-Vlachopoulou
Publikováno v:
Cancer Research and Treatment. 54:1053-1064
Purpose Angiogenesis is a crucial phenomenon in the development and progression of breast cancer (BC), but the clinical significance of angiogenesis-related proteins in metastatic BC remains unknown. This study investigates the prognostic value of va
Autor:
Flora Zagouri, Georgia-Angeliki Koliou, Foteinos Dimitrakopoulos, Christos Papadimitriou, Ioannis Binas, Angelos Koutras, Pavlos Papakostas, Christos Markopoulos, Vasileios Venizelos, Grigorios Xepapadakis, Charisios Karanikiotis, Amanda Psyrri, Dimitrios Bafaloukos, Paris Kosmidis, Gerasimos Aravantinos, Eleni Res, Davide Mauri, Anna Koumarianou, Kalliopi Petraki, Anna Tsipoura, Dimitrios Pectasides, Helen Gogas, George Fountzilas
Publikováno v:
Cancer Research. 82:P1-12
Background: Dose-dense sequential chemotherapy based on anthracyclines and taxanes has achieved an 18% reduction of recurrence risk in the adjuvant setting of early breast cancer (BC). However, the optimal chemotherapy schedule and the preferable int
Autor:
Flora Zagouri, Georgia-Angeliki Koliou, Foteinos Dimitrakopoulos, Christos Papadimitriou, Ioannis Binas, Angelos Koutras, Pavlos Papakostas, Christos Markopoulos, Vasileios Venizelos, Grigorios Xepapadakis, Αngeliki Andrikopoulou, Charisios Karanikiotis, Amanda Psyrri, Dimitrios Bafaloukos, Paris Kosmidis, Gerasimos Aravantinos, Eleni Res, Davide Mauri, Anna Koumarianou, Kalliopi Petraki, Anna Tsipoura, Dimitrios Pectasides, Helen Gogas, George Fountzilas
Publikováno v:
Br J Cancer
BACKGROUND: Dose-dense sequential chemotherapy with anthracyclines and taxanes achieved an 18% reduction of recurrence risk in early breast cancer (BC). The optimal chemotherapy schedule and interval between cycles remain under investigation. METHODS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71d12c3b75e98f52121a3ff58e187863
https://europepmc.org/articles/PMC9381581/
https://europepmc.org/articles/PMC9381581/
Autor:
Flora Zagouri, Dimitrios Bafaloukos, Anna Koumarianou, Eleni Giannoulatou, Amanda Psyrri, Christos Christodoulou, Christos Papadimitriou, Thomas Makatsoris, Ioannis Varthalitis, Georgia Angeliki Koliou, Apostolia Maria Tsimberidou, Gerasimos Aravantinos, Ioannis Tikas, Helena Linardou, Paris Kosmidis, George Papatsibas, Epaminontas Samantas, Dimitrios Pectasides, George Fountzilas, Sofia Chrisafi, Kyriaki Papadopoulou, Helen Gogas, Pavlos Papakostas, Jianhua Zhang, Andrew Futreal, Angelos Koutras, Elena Fountzilas, Georgios Pentheroudakis, Vassiliki Kotoula, Evangelia Razis
Publikováno v:
Oncotarget
Background: We evaluated the association between pathogenic mutations and overall survival (OS) in patients with cancer referred to Hellenic Cooperative Oncology Group-affiliated Departments. Patients and methods: Patients referred from 12/1980 to 1/
Autor:
Ilias Athanasiadis, Dimitrios Pectasides, George Fountzilas, Kyriakos Chatzopoulos, Kyriaki Papadopoulou, George Pentheroudakis, Irene Nicolaou, Emmanouil Saloustros, Helen Gogas, Gerasimos Aravantinos, Adamantia Nikolaidi, Flora Zagouri, Iliada Bompolaki, Niki Arnogiannaki, Eleni Giannoulatou, Pavlos Papakostas, Mattheos Bobos, Vassiliki Kotoula, Georgia-Angeliki Koliou, Georgios Oikonomopoulos
Publikováno v:
Cancer Genomics - Proteomics. 17:181-193
BACKGROUND/AIM: Age may pertain to different tumor genotype characteristics which may interfere with treatment efficacy and prognosis. We investigated the distribution and prognostic effect of mutations and tumor infiltrating lymphocyte (stromal TIL
Autor:
Nikolaos Ziras, C. Kalofonos, Christos N. Papandreou, Pavlos Papakotoulas, Ioannis Boukovinas, Georgios Koumakis, Georgios Samelis, Helen Stergiou, Eleni Timotheadou, Evangelos Bournakis, Athina Christopoulou, Georgios Papatsimpas, Athanasios Athanasiadis, Gerasimos Aravantinos, Alexandros Bokas, Alexandros Ardavanis, Paris Makrantonakis, Ioannis Varthalitis, Maria Souggleri, Pavlos Papakostas, Epameinondas Samantas, Charalambos Andreadis, Nikolaos Tsoukalas, Anastasios Grivas, Sofia Tripodaki, Georgios Pentheroudakis
Publikováno v:
Anticancer Research. 40:305-313
Background Cancer-associated thrombosis (CAT), the second leading cause of death in patients with cancer can be treated with low molecular weight heparin (LMWH) according to guidelines. Patients and methods A multicenter prospective observational stu
Autor:
Christina Bamia, Epaminontas Samantas, Georgia Kafiri, Dimitrios Bafaloukos, George Fountzilas, Sofia Chrisafi, Ioannis Efstratiou, Dimitrios Pectasides, Kyriaki Papadopoulou, Iliada Bombolaki, George Pentheroudakis, Thomas Makatsoris, Leonidas Mavroeidis, Georgia-Angeliki Koliou, Kyriakos Chatzopoulos, Kalliopi Petraki, Helen P. Kourea, George Papatsibas, Vassiliki Kotoula, Pavlos Papakostas, Davide Mauri
Publikováno v:
Clinical Colorectal Cancer. 18:e370-e384
Background Alternative splicing of vascular endothelial growth factor A (VEGFA) results in VEGFAxxxb antiangiogenic isoforms that fail to activate angiogenesis. Bevacizumab, widely used in patients with metastatic colorectal cancer (CRC), binds both
Autor:
Evangelia Moirogiorgou, Eleni Res, Christos Christodoulou, D. Tryfonopoulos, I. Binas, Mattheos Bobos, Kyriakos Chatzopoulos, Dimitrios Bafaloukos, Amanda Psyrri, Irene Nicolaou, George Pentheroudakis, Christina Magkou, Kyriaki Papadopoulou, Vassiliki Rapti, Dimitrios Pectasides, George Fountzilas, Sofia Chrisafi, Athanasios Alexopoulos, Maria Sotiropoulou, Pavlos Papakostas, Athanasios Kotsakis, Angelos Koutras, Vassiliki Kotoula, Georgia-Angeliki Koliou, Evangelia Razis
Publikováno v:
Oncol Lett
Prognostic and predictive biomarkers are being studied for the diagnosis and treatment of breast cancer. The present study retrospectively assessed the mRNA expression of HER family receptor ligands and of other potential prognostic biomarkers and th
Autor:
Athina Christopoulou, Alexandros Ardavanis, Christos Papandreou, Georgios Koumakis, Georgios Papatsimpas, Pavlos Papakotoulas, Nikolaos Tsoukalas, Charalambos Andreadis, Georgios Samelis, Pavlos Papakostas, Gerasimos Aravantinos, Nikolaos Ziras, Maria Souggleri, Charalambos Kalofonos, Epameinondas Samantas, Paris Makrantonakis, Georgios Pentheroudakis, Athanasios Athanasiadis, Helen Stergiou, Alexandros Bokas, Anastasios Grivas, Elli-Sofia Tripodaki, Ioannis Varthalitis, Eleni Timotheadou, Ioannis Boukovinas
Publikováno v:
Oncology letters. 23(4)
Thromboprophylaxis, as a preventive measure for cancer-associated thrombosis (CAT), may be beneficial for patients with active cancer and high-risk for thrombosis. The present post hoc analysis include a total of 407 patients enrolled in the Greek Ma
Autor:
Dimitris Bafaloukos, Amanta Psyrri, Kyriaki Papadopoulou, Angelos Koutras, Konstantine T. Kalogeras, Athanasios Kotsakis, Georgia-Angeliki Koliou, Gerasimos Aravantinos, Evangelia Razis, George Pentheroudakis, Vassiliki Kotoula, Panagiota Economopoulou, Georgios Lazaridis, Christos Christodoulou, Petroula Arapantoni-Dadioti, Theofanis Economopoulos, Helen Patsea, Pavlos Papakostas, Epaminondas Samantas, Dimitrios Pectasides, Kitty Pavlakis, George Fountzilas
Publikováno v:
Translational Oncology
Translational Oncology, Vol 12, Iss 5, Pp 739-748 (2019)
Translational Oncology, Vol 12, Iss 5, Pp 739-748 (2019)
BACKGROUND: Src, CDKN1B, and JAK2 play a crucial role in the coordination of cell signaling pathways. In the present study, we aim to investigate the prognostic significance of these biomarkers in HER2-positive metastatic breast cancer (MBC) patients